PDF herunterladen
Psychother Psychosom Med Psychol 2002; 52(3/4): 166-172
DOI: 10.1055/s-2002-24960
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Autonome Neuropathie bei Patienten mit Somatisierungsstörungen

Autonomic Neuropathy in Somatization DisordersKurt  Laederach-Hofmann1, 2 , Lutz  Mussgay1 , Thomas  Wilde1 , Heinz  Rüddel1
  • 1Zentrum für Psychobiologie und Psychosomatik der Universität Trier, Psychosomatische Fachklinik St. Franziska-Stift, Bad Kreuznach
  • 2Psychosomatik und Psychosoziale Medizin der Universität Bern
Weitere Informationen

Publikationsverlauf

27. 7. 1999

25. 7. 2001

Publikationsdatum:
08. April 2002 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Ziel unserer Studie war die psychometrische Testung und Untersuchung der autonomen Funktionen von Patienten mit Somatisierungsstörung. Patienten und Methoden: 71 Patienten (32 Frauen und 39 Männer) mit der Diagnose Somatisierungsstörung (ICD-10 F45.0) wurden eingeschlossen und mittels standardisierter psychometrischer Evaluation und autonomer Testung nach Standardprotokoll untersucht. Anhand der Spektralanalyse konnten drei Gruppen identifiziert werden: eine solche (n = 12) mit pathologisch erniedrigter (unter 3 ms/mm Hg), eine andere mit normaler (über 9 ms/mm Hg) Barorezeptorsensitivität (n = 20) sowie eine dritte (n = 39) mit Werten zwischen 3,1 und 8,9 ms/mm Hg (Graubereich). Zusätzlich wurde eine 24-Stunden-Blutdruckmessung durchgeführt, um mögliche Effekte einer gestörten autonomen Regulation auf den Blutdruck zu erfassen. Resultate: Die zwei Extremgruppen unterschieden sich in keiner Weise betreffend der psychometrischen Instrumente (GBB, STAXI, STAI, ADS, SCL-90-R, FPI, SOMS). In der Spektralanalyse zeigten sich in einer Kovarianzanalyse (Alter) signifikant tiefere Werte bei Patienten mit erniedrigter BRS im mid-frequency band (p < 0,01). Der 24-Stunden-Blutdruckverlauf zeigte ebenfalls signifikant höhere nächtliche Blutdruckwerte bei den Patienten mit pathologisch erniedrigter Barorezeptorsensitivität (p zwischen 0,05 und 0,001). Schlussfolgerung: Obwohl bei Patienten mit Somatisierungsstörungen eine nichtorganische Ursache für die Erklärung der Beschwerden postuliert wird, weist ein hoher Prozentsatz abnorme Werte in der autonomen Testung und signifikant höhere Blutdruckwerte im Tagesprofil auf.

Abstract

Aim: We conducted a study to investigate whether patients with somatization disorder show abnormal values in autonomic testing, especially in the central baroreceptor sensitivity. Patients and Methods: Seventy-one patients were included. All had a diagnosis of somatization disorder (ICD-10, F45.0). Psychometric testing was performed by means of validated questionnaires (STAI, STAXI, FPI, GBB, ADS, SOMS, SCL-90-R). Autonomic regulation was analyzed by international standards using frequency spectral calculation by fast Fourier transformation. Thereby 3 different groups were detected: 12 patients with a baroreceptor sensitivity (BRS) of less than 3.0 ms/mm Hg, 20 patients with normal BRS (> 9.0 ms/mm Hg), and an in-between group (n = 39) with intermediate BRS. Controlling for age, a covariance analysis was calculated. Results: The two extreme groups showed no difference in psychometric testing. However, significant differences were discernible in spectral values of mid-frequency-band (p < 0.05) in a covariance analysis with age as covariate. Equally the 24 h blood pressure determination showed significantly higher values for the group with BRS < 3.0 ms/mm Hg (p < 0.05 to 0.001). Conclusions: In a high percentage (17 %) of patients diagnosed to have somatization disorder autonomic dysregulation becomes apparent and is accompanied by increased blood pressure. Therefore it doesn't seem accurate to overlook concomitant organic lesions in somatization disorders despite patients lacking overtly clinical signs but suffering from various unspecific symptoms.

Key words

Autonomic testing - Somatization disorder - Baroreceptor sensitivity - Spectral analysis - Blood pressure profile - Psychometric assessment

Literatur

  • 1 Cooper J. (ed) .WHO Pocket book to ICD-10 classification of mental and behavioural disorders.  Vol. German Edition, edited by Dilling H, Freyberger HJ. New York; Churchill Livingstone 1994: 175-183
    Google Scholar
  • 2 Frances A, Mack A H, First M B. et al . DMS-IV meets philosophy.  J Med Philos. 1994;  19 207-218
    PubMedGoogle Scholar
  • 3 Stewart A L, Hays R D, Wells K B. et al . Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study.  J Clin Epidemiol. 1994;  47 719-730
    CrossrefPubMedGoogle Scholar
  • 4 Hartman D. Missed diagnoses and misdiagnoses of environmental toxicant exposure. The psychiatry of toxic exposure and multiple chemical sensitivity.  Psychiatr Clin North Am. 1998;  21 659-670
    CrossrefPubMedGoogle Scholar
  • 5 Goldenberg D. Fibromyalgia syndrome a decade later: what have we learned?.  Arch Intern Med. 1999;  159 777-785
    CrossrefPubMedGoogle Scholar
  • 6 Feinberg M. The problems of anticholinergic adverse effects in older patients.  Drugs Aging. 1993;  3 335-348
    PubMedGoogle Scholar
  • 7 Rozansky A, Bairey C, Krantz D. et al . Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease.  New England Journal of Medicine. 1988;  318 1005-1012
    PubMedGoogle Scholar
  • 8 Malfatto G, Facchini M, Sala L. et al . Effect of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction.  Am J Cardiol. 1998;  81 834-840
    CrossrefPubMedGoogle Scholar
  • 9 Zwillich C. Sleep apnoea and autonomic function.  Thorax. 1999;  53, (Suppl 3) S20-S24
    PubMedGoogle Scholar
  • 10 Schafer H, Koehler U, Hasper E. et al . Schlafapnoe und kardiovaskuläres Risiko.  Z Kardiol. 1995;  84 871-884
    PubMedGoogle Scholar
  • 11 O'Brien I, McFadden J, Corrall R. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes.  Quartely Journal of Medicine. 1991;  290 495-502
    PubMedGoogle Scholar
  • 12 Bergström B, Liljia B, Oesterlin S, Sundkvist G. Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity.  Journal of Internal Medicine. 1990;  227 57-63
    PubMedGoogle Scholar
  • 13 Laederach-Hofmann K, Mussgay L, Rüddel H. Autonomic cardiovascular regulation in obesity.  J Endocrinology. 2000;  164 59-66
    PubMedGoogle Scholar
  • 14 Mussgay L, Laederach-Hofmann K, Rüddel H. Autonomic cardiovascular regulation in obesity.  Journal of Psychophysiology. 1998;  12 396
    PubMedGoogle Scholar
  • 15 Lapidus L, Bengtsson C, Hallstrom T, Bjorntorp P. Obesity, adipose tissue distribution and health in women: Results from a population study in Gothenburg, Sweden.  Appetite. 1989;  13 25-35
    CrossrefPubMedGoogle Scholar
  • 16 Hohnloser S. Untersuchung der Barorezeptorfunktion.  D Ärzteblatt. 1999;  33 1365-1368
    PubMedGoogle Scholar
  • 17 Lawrence I G, Weston P J, Bennett M A. et al . Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus?.  Diabet Med. 1997;  14 82-85
    CrossrefPubMedGoogle Scholar
  • 18 Olshan A, O'Connor D, Cohen I. et al . Baroreflex dysfunction in patients with adult-onset diabetes and hypertension.  Am J Med. 1983;  74 233-242
    CrossrefPubMedGoogle Scholar
  • 19 Ferrer M, Kennedy W, Sahinen F. Baroreflexes in patients with diabetes mellitus.  Neurology. 1991;  41 1462-1466
    PubMedGoogle Scholar
  • 20 Weston P, James M, Panerai R, McNally P. et al . Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic functions in patients with insulin-dependent diabetes mellitus.  Clinical Sciences (Colch). 1996;  91 59-64
    PubMedGoogle Scholar
  • 21 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology . Heart rate variability. Standards of measurement, physiological interpretation and clinical use.  Circulation. 1996;  93 1043-1065
    Google Scholar
  • 22 Honzikova N, Fiser B, Honzik J. Noninvasive determination of baroreflex sensitivity in man by means of spectral analysis.  Physiol Res. 1992;  41 31-37
    PubMedGoogle Scholar
  • 23 Malliani A, Lombardi F, Pagani M. Power spectral analysis of heart rate variability: a tool to explore neuronal regulatory mechanisms.  Br Heart J. 1994;  71 1-2
    PubMedGoogle Scholar
  • 24 Mulder L. Assessment of cardiovascular reactivity by means of spectral analysis. Groningen; Universität 1988
    Google Scholar
  • 25 Robbe H W, Mulder L J, Rüddel H. et al . Assessment of baroreceptor reflex sensitivity by means of spectral analysis.  Hypertension. 1987;  10 538-543
    CrossrefPubMedGoogle Scholar
  • 26 Henningsen P. Conversion disorder: psychosomatic aspects instead of psychogenesis?.  Psychother Psychosom med Psychol. 1996;  46 391-399
    PubMedGoogle Scholar
  • 27 Schmeling-Kludas C, Odensass C. Psychosomatic medicine in the general hospital: problem spectrum in a random sample of 100 internal medicine patients.  Psychother Psychosom med Psychol. 1994;  44 372-381
    PubMedGoogle Scholar
  • 28 Verhaak P, Tijhuis M. The somatizing patient in general practice.  Int J Psychiatry Med. 1994;  24 157-177
    PubMedGoogle Scholar
  • 29 Cassileth B R, Lusk E J, Strouse T B. et al . Psychosocial status in chronic illness: A comparative analysis of six diagnostic groups.  New Engl J Med. 1984;  311 506-511
    PubMedGoogle Scholar
  • 30 Portegijs P J, Jeuken F M, van der Horst F G. et al . A troubled youth: relations with somatization, depression and anxiety in adulthood.  Fam Pract. 1996;  13 1-11
    PubMedGoogle Scholar
  • 31 Rief W, Shaw R, Fichter M. Elevated levels of psychophysiological arousal and cortisol in patients with somatoform disorders.  Psychosomatic Medicine. 1998;  60 198-203
    PubMedGoogle Scholar
  • 32 Pagani M, Lucini D. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system.  Clin Sci (Colch). 1999;  96 117-125
    PubMedGoogle Scholar
  • 33 Neumann C, Schmid H. The relationship between the degree of cardiovascular autonomic dysfunction and symptoms of neuropathy and other complications of diabetes mellitus.  Braz J Med Biol Res. 1995;  28 751-757
    PubMedGoogle Scholar
  • 34 Laederach-Hofmann K, Mussgay L, Schill H, Rüddel H. Wie lassen sich Körperbeschwerden bei Patienten mit Diabetes mellitus ohne pathologische klinische Befunde verstehen?.  Psychotherapie, Psychosomatik und medizinische Psychologie. 1999;  50 169-175
    PubMedGoogle Scholar
  • 35 Berntson G, Bigger T, Eckberg D. et al . Heart rate variability: origins, methods, and interpretative caveats.  Psychophysiology. 1997;  34 623-648
    CrossrefPubMedGoogle Scholar
  • 36 Stys A, Stys T. Current clinical applications of heart rate variability.  Clin Cardiol. 1998;  21 719-724
    PubMedGoogle Scholar
  • 37 Honzikova N, Semrad B, Fiser B, Labrova R. Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction.  Physiol Res. 2000;  49 643-650
    PubMedGoogle Scholar
  • 38 Maestri R, Pinna G D, Mortara A. et al . Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques.  J Am Coll Cardiol. 1998;  31 344-351
    PubMedGoogle Scholar
  • 39 Brähler E, Scheer J. Der Gießener Beschwerdebogen GBB. Bern; Huber 1995 2. Ausgabe
    Google Scholar
  • 40 Schwenkmezger P, Hodapp V. A questionnaire for assessing anger and expression of anger.  Z Klin Psychol Psychopathol Psychother. 1991;  39 63-68
    PubMedGoogle Scholar
  • 41 Franke H. SCL-90-R: Die Symptom-Checkliste von Derogatis, Deutsche Version ed. Belz-Test. Göttingen; Belz Test GmbH 1995
    Google Scholar
  • 42 Laux L, Glanzmann P, Schaffner P, Spielberger C D. Das State-Trait-Angstinventar. Weinheim; Beltz 1981
    Google Scholar
  • 43 Fahrenberg J, Hampel R, Seig H. Das Freiburger Persönlichkeitsinventar FPI. Göttingen; Hogrefe 1989
    Google Scholar
  • 44 Schulz H, Lotz-Rambaldi W, Koch U. et al . 1-Year follow-up of inpatient treatment in a psychosomatic rehabilitation clinic with either a psychoanalytic or behavior therapy oriented treatment.  Psychother Psychosom med Psychol. 1999;  49 114-130
    PubMedGoogle Scholar
  • 45 Rief W, Hiller W, Heuser J. Das Screening für Somatoforme Störungen. Manual zum Fragebogen.  ed. Rief W. Prien a Chiemsee; Medizinisch-Psychosomatische Klinik Roseneck 1996
    Google Scholar
  • 46 Mulder L. Carspan 2.0, P.O. Box 841, in Cardiac parameter evaluation program. Groningen; IEC proGamma 1991
    Google Scholar
  • 47 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology . Various Heart rate variability. Standards of measurement, physiological interpretation, and clinical use.  Eur Heart J. 1996;  17 354-381
    PubMedGoogle Scholar
  • 48 Lishner M, Akselrod S, Avi M. et al . Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus.  Journal of the Autonomic Nervous System. 1987;  19 119-125
    CrossrefPubMedGoogle Scholar
  • 49 Honzikova N, Fiser B, Semrad B. Critical value of baroreflex sensitivity determined by spectral analysis in risk stratification after myocardial infarction.  Pacing Clin Electrophysiol. 2000;  23 (11Pt2) 1965-1967
    PubMedGoogle Scholar
  • 50 Dawson S L, Robinson T G, Youde J H. et al . Older subjects show no age-related decrease in cardiac baroreceptor sensitivity (see comments).  Age Ageing. 1999;  28 347-353
    CrossrefPubMedGoogle Scholar
  • 51 Laederach-Hofmann K, Mussgay L, Winter A . et al . Early autonomic dysfunction in patients with diabetes mellitus assessed by spectral analysis of heart rate and blood pressure variability.  Clin Physiol. 1999;  19 97-106
    CrossrefPubMedGoogle Scholar
  • 52 Veglio M, Carpano-Maglioli P, Tonda L. et al . Autonomic neuropathy in non-insulin dependent diabetic patients: Correlations with age, sex, duration and metabolic control of diabetes.  Diabetes & Metabolism. 1990;  16 200-206
    PubMedGoogle Scholar
  • 53 Infrasca R. Alexithymia, neurovegetative arousal and neuroticism. An experimental study.  Psychother Psychosom. 1997;  66 276-280
    PubMedGoogle Scholar
  • 54 Friedman B, Thayer J. Autonomic balance revisited: panic anxiety and heart rate variability.  J Psychosom Res. 1998;  44 133-151
    CrossrefPubMedGoogle Scholar
  • 55 Klein E, Cunam E, Hasel T. et al . Altered heart rate variability in panic disorder patients.  Biol Psychiatry. 1995;  37 18-24
    CrossrefPubMedGoogle Scholar
  • 56 Yeragani V, Balon R, Pohl R. et al . Decreased R-R variance in panic disorder patients.  Acta Psychiatr Sand. 1990;  81 554-559
    PubMedGoogle Scholar
  • 57 Videbech P, Ravnkilde B, Fiirgaard B. et al . Structural brain abnormalities in unselected in-patients with major depression.  Acta Psychiatr Scand. 2001;  103 282-286
    CrossrefPubMedGoogle Scholar
  • 58 Weston P J, Gill G V. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The „dead in bed” syndrome revisited (see comments).  Diabet Med. 1999;  16 626-631
    CrossrefPubMedGoogle Scholar
  • 59 Töyry J, Niskanen L, Länsimies E. et al . Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus.  Stroke. 1996;  27 1316-1318
    PubMedGoogle Scholar
  • 60 Mussgay L, Rüddel H. Die Analyse autonomer Regulationsmechanismen als Entscheidungshilfe in der Diagnostik somatoformer Beschwerden bei Patienten mit langjähriger Umweltgift-Exposititon.  Z Umweltmedizin. 1998;  6 30-35
    PubMedGoogle Scholar
  • 61 Fleet R, Beitman B. Cardiovascular death from panic disorder and panic-like anxiety: a critical review of the literature.  J Psychosom Res. 1998;  44 71-80
    CrossrefPubMedGoogle Scholar

Dr. Kurt Laederach-Hofmann

Psychosomatik, Essstörungen, ANS · Psychiatrische Universitätspoliklinik Bern

3010 Bern-Inselspital · Schweiz

eMail: laederach@insel.ch

      >